189 related articles for article (PubMed ID: 9034694)
21. The cognitive risk profile for pain: development of a self-report inventory for identifying beliefs and attitudes that interfere with pain management.
Cook AJ; Degood DE
Clin J Pain; 2006 May; 22(4):332-45. PubMed ID: 16691085
[TBL] [Abstract][Full Text] [Related]
22. The effects of ECT on cognitive functioning in the elderly: a review.
Tielkes CE; Comijs HC; Verwijk E; Stek ML
Int J Geriatr Psychiatry; 2008 Aug; 23(8):789-95. PubMed ID: 18311845
[TBL] [Abstract][Full Text] [Related]
23. Electroconvulsive therapy: a review of knowledge, experience and attitudes of patients concerning the treatment.
Chakrabarti S; Grover S; Rajagopal R
World J Biol Psychiatry; 2010 Apr; 11(3):525-37. PubMed ID: 20128713
[TBL] [Abstract][Full Text] [Related]
24. Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.
Ueda S; Koyama K; Okubo Y
J ECT; 2010 Jun; 26(2):111-5. PubMed ID: 20386461
[TBL] [Abstract][Full Text] [Related]
25. Predicting efficacy of electroconvulsive therapy in major depressive disorder.
Tsuchiyama K; Nagayama H; Yamada K; Isogawa K; Katsuragi S; Kiyota A
Psychiatry Clin Neurosci; 2005 Oct; 59(5):546-50. PubMed ID: 16194256
[TBL] [Abstract][Full Text] [Related]
26. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
27. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
28. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
Schaeffer E; Wciórka J
Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic variability and therapeutic efficacy of ECT in Nepalese sample.
Ahikari SR; Pradhan SN; Sharma SC; Shrestha BR; Shrestha S; Tabedar S
Kathmandu Univ Med J (KUMJ); 2008; 6(1):41-8. PubMed ID: 18604114
[TBL] [Abstract][Full Text] [Related]
30. A study of the clinical efficacy of maintenance ECT.
Thienhaus OJ; Margletta S; Bennett JA
J Clin Psychiatry; 1990 Apr; 51(4):141-4. PubMed ID: 2324077
[TBL] [Abstract][Full Text] [Related]
31. An efficacy study of single- versus double-seizure induction with ECT in major depression.
Roemer RA; Dubin WR; Jaffe R; Lipschutz L; Sharon D
J Clin Psychiatry; 1990 Nov; 51(11):473-8. PubMed ID: 2228983
[TBL] [Abstract][Full Text] [Related]
32. Response to ECT in bipolar I, bipolar II and unipolar depression.
Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
[TBL] [Abstract][Full Text] [Related]
33. Use of electroconvulsive therapy in adolescents.
Cohen D; Paillère-Martinot ML; Basquin M
Convuls Ther; 1997 Mar; 13(1):25-31. PubMed ID: 9152585
[TBL] [Abstract][Full Text] [Related]
34. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
35. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
Matthews JD; Blais M; Park L; Welch C; Baity M; Murakami J; Sklarsky K; Homberger C; Fava M
J Psychiatr Res; 2008 Jun; 42(7):526-31. PubMed ID: 17681545
[TBL] [Abstract][Full Text] [Related]
36. Prolactin release and clinical response to electroconvulsive therapy in depressed geriatric inpatients: a preliminary report.
Clark CP; Alexopoulos GS; Kaplan J
Convuls Ther; 1995 Mar; 11(1):24-31. PubMed ID: 7796064
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life following ECT in a large community sample.
McCall WV; Prudic J; Olfson M; Sackeim H
J Affect Disord; 2006 Feb; 90(2-3):269-74. PubMed ID: 16412519
[TBL] [Abstract][Full Text] [Related]
38. The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS).
Franken IH; Rassin E; Muris P
J Affect Disord; 2007 Apr; 99(1-3):83-9. PubMed ID: 16996138
[TBL] [Abstract][Full Text] [Related]
39. Subjective memory complaints prior to and following electroconvulsive therapy.
Coleman EA; Sackeim HA; Prudic J; Devanand DP; McElhiney MC; Moody BJ
Biol Psychiatry; 1996 Mar; 39(5):346-56. PubMed ID: 8704066
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression.
McCormick LM; Yamada T; Yeh M; Brumm MC; Thatcher RW
J Psychiatr Res; 2009 Feb; 43(5):553-60. PubMed ID: 18851858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
